Ganga Pharmaceuticals- Standalone HY1-FY21 PAT dips to Rs 1.65 lacs against Rs. 15.53 lacs in HY1-FY20
Ganga Pharmaceuticals- HY1-FY21 Earning per share was Rs.0.04 which is the same to the EPS in HY1-FY20.
Company : Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals announced its standalone financials for the half year ended on 30thsept, 2020.
Following are the standalone financial figures for the HY1-FY2021 at Ganga Pharmaceuticals:- Net profit falls to Rs.1.65 lacs against Rs. 15.53 lacs in a year ago period. - Revenue stood at Rs.1.21 crore whereas last year corresponding period it was Rs.1.45 crore. - Earning per share was Rs.0.04which is the same to the EPS in HY1-FY20.
By the end of financial year 2019-20, standalone total revenue at Ganga Pharmaceuticals reached Rs.3.24 crore against Rs.3.50 crore a year ago. PAT for FY20 was Rs.18.88 lacs while last year it was Rs. 18.71 lacs. Standalone EPS was Rs.0.46 against the same EPS last year.